EA200600012A1 - POLYMORPHISM OF THE NERS1 HUMAN GENE, USEFUL FOR DIAGNOSIS OF HERITAGE PREDISPOSITION TO CANCER - Google Patents

POLYMORPHISM OF THE NERS1 HUMAN GENE, USEFUL FOR DIAGNOSIS OF HERITAGE PREDISPOSITION TO CANCER

Info

Publication number
EA200600012A1
EA200600012A1 EA200600012A EA200600012A EA200600012A1 EA 200600012 A1 EA200600012 A1 EA 200600012A1 EA 200600012 A EA200600012 A EA 200600012A EA 200600012 A EA200600012 A EA 200600012A EA 200600012 A1 EA200600012 A1 EA 200600012A1
Authority
EA
Eurasian Patent Office
Prior art keywords
cancer
predisposition
ners1
heritage
polymorphism
Prior art date
Application number
EA200600012A
Other languages
Russian (ru)
Other versions
EA011608B1 (en
Inventor
Цезарий Цыбульский
Ян Любинский
Бохдан Горски
Бартломей Глиневич
Андржей Сикорский
Академя Медычна Поморска
Original Assignee
Цезарий Цыбульский
Ян Любинский
Горский, Бохдан
Бартломей Глиневич
Андржей Сикорский
Академя Медычна Поморска
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Цезарий Цыбульский, Ян Любинский, Горский, Бохдан, Бартломей Глиневич, Андржей Сикорский, Академя Медычна Поморска filed Critical Цезарий Цыбульский
Publication of EA200600012A1 publication Critical patent/EA200600012A1/en
Publication of EA011608B1 publication Critical patent/EA011608B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Abstract

Данное изобретение относится к способам и наборам для определения предрасположенности и к протоколам обследования развития рака, например рака простаты и/или молочной железы, основанных на наследственной мутации гена NBS1.This invention relates to methods and kits for determining predisposition and to protocols for examining the development of cancer, for example, prostate and / or breast cancer, based on the hereditary mutation of the NBS1 gene.

EA200600012A 2003-06-13 2004-06-14 Polymorphism in the human nbs1 gene useful in diagnostic of inherited predisposition to cancer EA011608B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PL360642A PL201608B1 (en) 2003-06-13 2003-06-13 Method and set designed for detection of high genetic predisposition for prostate gland cancer as well as use of germinal change within the NBS1 gene
PCT/PL2004/000044 WO2004111272A2 (en) 2003-06-13 2004-06-14 Polymorphism in the human nbs1 gene useful in diagnostic of inherited predisposition to cancer

Publications (2)

Publication Number Publication Date
EA200600012A1 true EA200600012A1 (en) 2007-08-31
EA011608B1 EA011608B1 (en) 2009-04-28

Family

ID=33550530

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200600012A EA011608B1 (en) 2003-06-13 2004-06-14 Polymorphism in the human nbs1 gene useful in diagnostic of inherited predisposition to cancer

Country Status (4)

Country Link
EA (1) EA011608B1 (en)
PL (1) PL201608B1 (en)
UA (1) UA93344C2 (en)
WO (1) WO2004111272A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11261494B2 (en) 2012-06-21 2022-03-01 The Chinese University Of Hong Kong Method of measuring a fractional concentration of tumor DNA
ES2908347T3 (en) 2015-02-10 2022-04-28 Univ Hong Kong Chinese Mutation detection for cancer screening and fetal analysis
ES2960201T3 (en) 2015-07-23 2024-03-01 Univ Hong Kong Chinese Analysis of acellular DNA fragmentation patterns
SG11201906397UA (en) 2017-01-25 2019-08-27 Univ Hong Kong Chinese Diagnostic applications using nucleic acid fragments

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999055716A1 (en) * 1998-04-27 1999-11-04 Virginia Mason Research Center A gene associated with nijmegen breakage syndrome, its gene product and methods for their use

Also Published As

Publication number Publication date
PL201608B1 (en) 2009-04-30
WO2004111272A2 (en) 2004-12-23
PL360642A1 (en) 2004-12-27
EA011608B1 (en) 2009-04-28
WO2004111272A3 (en) 2005-06-09
UA93344C2 (en) 2011-02-10

Similar Documents

Publication Publication Date Title
WO2007016548A3 (en) Micro-rna-based methods and compositions for the diagnosis, prognosis and treatment of breast cancer
ATE470723T1 (en) GENE EXPRESSION MARKERS FOR BREAST CANCER PROGNOSIS
WO2006020269A3 (en) Biomarkers of neurodegenerative disease
WO2007064776A3 (en) Markers for breast cancer
WO2004066941A3 (en) Expression profiles for colon cancer and methods of use
WO2004067570A3 (en) Prostate cancer diagnosis and treatment
DE60214134D1 (en) MODIFIED PSMA LIGANDS AND THEIR USE
WO2004044218A3 (en) Methods and materials for examining pathways associated with glioblastoma progression
ATE483825T1 (en) COMPOSITIONS FOR IDENTIFYING ADENOVIRUSES
WO2006047484A3 (en) Molecular analysis of cellular fluid and liquid cytology specimens for clinical diagnosis, characterization, and integration with microscopic pathology evaluation
WO2005044990A3 (en) Use of differentially expressed nucleic acid sequences as biomarkers for cancer
IL174195A0 (en) Compositions, reagents and kits for and methods of diagnosing, monitoring and treating obesity and/or diabetes
ATE515575T1 (en) METHODS AND PROBE FOR DETECTING CANCER
EA200970891A1 (en) GENETIC OPTIONS OF CHR2 AND CHR16 AS MARKERS FOR APPLICATION IN RISK ASSESSMENT, DIAGNOSTICATION, PREDICTION AND TREATMENT OF BREAST CANCER
ATE454468T1 (en) DETECTION OF THE INSTABILITY OF MICROSATELLITES AND USE THEREOF IN TUMOR DIAGNOSIS
AU2003293141A1 (en) Methods for identifying risk of breast cancer and treatments thereof
WO2005085863A3 (en) Biomarker: compound correlations in cancer diagnosis and therapy
MX2009001937A (en) Biomarkers for alzheimer's disease progression.
DK2054443T3 (en) Antibodies to an epitope from AGR2, assays and hybridomas
WO2006091861A3 (en) Compositions and methods relating to cns lymphoma
DE60126248D1 (en) USE OF BREAST CANCER MEMBRANE PROTEINS FOR TREATMENT, PROPHYLAXIS AND DIAGNOSIS OF BREAST CANCER
ATE513929T1 (en) GENES AFFECTING HUMAN MEMORY PERFORMANCE
EA200600012A1 (en) POLYMORPHISM OF THE NERS1 HUMAN GENE, USEFUL FOR DIAGNOSIS OF HERITAGE PREDISPOSITION TO CANCER
WO2003105773A3 (en) Activating mutations of platelet derived growth factor receptor alpha (pdgfra) as diagnostic markers and therapeutic targets:
DE602005023329D1 (en) METHOD FOR DIAGNOSIS OF NON-SMALL CELL LUNG CARCINOMAS USING URLC8'S TRNA DIHYDROURIDINE SYNTHASE ACTIVITY

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KZ KG MD TJ TM

TC4A Change in name of a patent proprietor in a eurasian patent
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): BY RU